Medication info
Salotan Tablets 100 mg (Losartan Potassium)

Salotan Tablets 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White, droplet-shaped film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200802066 · Notified 2008.02.22 · Insurance code 643304570

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to a maximum of 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to a maximum of 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older, weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension, particularly helping to improve kidney disease in patients with type 2 diabetes who have hypertension. It effectively lowers blood pressure to reduce the burden on the heart and blood vessels, and helps to protect kidney function. Therefore, it is used to prevent and improve kidney damage caused by hypertension and diabetes.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to a maximum of 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to a maximum of 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older, weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not use if allergic to this medication or if you have severe liver impairment or certain hereditary angioedema conditions. Elderly patients, those with compromised kidney function, or patients with heart disease should exercise particular caution when using this medication and must frequently monitor blood pressure and electrolyte levels. This medication lowers blood pressure, which can lead to dizziness or fainting due to sudden drops in blood pressure, so caution is necessary during the initial dosage or when increasing the dose. Additionally, this medication may elevate blood potassium levels, so it should not be taken with potassium supplements or medications containing potassium. Patients at risk for hyperkalemia should have regular blood tests. While taking this medication, liver or kidney function abnormalities may occur, so any unusual symptoms should be reported to healthcare professionals immediately. Caution is required when driving or operating machinery due to potential dizziness while taking this medication. There may be interactions when taken with other antihypertensives, diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), so inform your doctor of all medications you are taking. In case of overdose, hypotension and cardiac abnormalities may occur; adhere to the prescribed dosage and seek immediate treatment if unusual symptoms appear. It is advisable not to use this medication in children or pediatric patients with low glomerular filtration rates, as there is insufficient safety data. Store this medication out of reach of children and be careful not to transfer it to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 138 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • abdominal distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • hyperesthesia
  • paresthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • thoracic discomfort
  • alopecia
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • frequency
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • dry cough
  • erythroderma
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • hypoglycemia
  • weight loss
  • delay in physical/behavioral development
  • increased mortality rate
  • nephrotoxicity
  • hypotension
  • hyperkalemia
  • intrauterine growth retardation
  • prematurity
  • patent ductus arteriosus
  • intrauterine fetal injury
  • oligohydramnios
  • fetal limb contractures
  • craniofacial dysgenesis
  • pulmonary hypoplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. This ensures that the efficacy and safety of the drug are preserved over time.

Appearance and packaging

Appearance

White, droplet-shaped film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.